Initiation and completion rates for latent tuberculosis infection treatment: A systematic review
Sandgren, A., Vonk Noordegraaf-Schouten, M., van Kessel, F., Stuurman, A., Oordt-Speets, A., van der Werf, M.J.
Interventions for improving adherence to treatment for latent tuberculosis infection: A systematic review
Stuurman, A.L., Vonk Noordegraaf-Schouten, M., van Kessel, F., Oordt-Speets, A.M., Sandgren, A., van der Werf, M.J.
Management of latent tuberculosis infection
When people with infectious tuberculosis (TB) cough, sneeze or otherwise exhale droplets, they expose others to Mycobacterium tuberculosis. After a person is exposed, they can be infected with M. tuberculosis without having TB disease and without signs and symptoms. This is called latent TB infection (LTBI).
Programmatic management of latent tuberculosis infection in the European Union
Programmatic management of latent tuberculosis infection (LTBI) is a key component of the global tuberculosis (TB) elimination strategy. This document provides evidence-based guidance for the implementation of programmatic management of LTBI in the European Union and European Economic Area (EU/EEA).